Short Interest in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Increases By 35.3%

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 2,300 shares, an increase of 35.3% from the February 28th total of 1,700 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average trading volume of 6,000 shares, the days-to-cover ratio is presently 0.4 days.

Wall Street Analysts Forecast Growth

Separately, Maxim Group initiated coverage on shares of STRATA Skin Sciences in a research report on Thursday, February 27th. They set a “buy” rating and a $6.00 target price on the stock.

STRATA Skin Sciences Stock Down 2.0 %

NASDAQ:SSKN traded down $0.06 during trading hours on Monday, reaching $2.66. The company’s stock had a trading volume of 4,316 shares, compared to its average volume of 12,128. The company has a debt-to-equity ratio of 1.62, a quick ratio of 0.94 and a current ratio of 1.13. The stock has a 50 day moving average price of $2.75 and a two-hundred day moving average price of $2.91. STRATA Skin Sciences has a 12 month low of $2.51 and a 12 month high of $5.90. The company has a market capitalization of $11.07 million, a P/E ratio of -1.00 and a beta of 1.32.

STRATA Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings results on Thursday, March 27th. The medical device company reported ($1.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.73). STRATA Skin Sciences had a negative return on equity of 69.33% and a negative net margin of 28.72%. The firm had revenue of $33.56 million for the quarter, compared to analyst estimates of $9.03 million. Equities analysts predict that STRATA Skin Sciences will post -1.05 EPS for the current fiscal year.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.